Literature DB >> 12707433

MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy.

A Fatemi1, P B Barker, A M Uluğ, L M Nagae-Poetscher, N J Beauchamp, A B Moser, G V Raymond, H W Moser, S Naidu.   

Abstract

OBJECTIVE: To utilize neuroimaging procedures to assess the extent of cerebral involvement in female subjects heterozygous for X-linked adrenoleukodystrophy (X-ALD).
METHODS: Brain MRI studies were performed in 76 female subjects heterozygous for X-ALD (mean age 43 years, range 8 to 75 years). Sixty-five had clinical evidence of spinal cord involvement resembling that in males with adrenomyeloneuropathy (AMN), two had clinical evidence of cerebral involvement, and nine showed no neurologic abnormality. Readers blinded to clinical findings further analyzed abnormal MRI studies. In eight women whose MRI results were normal, four-slice long echo time MRS imaging (MRSI) studies were performed and compared to those of eight age-matched controls.
RESULTS: MRI results were normal in 65 subjects and abnormal in 11. In eight of the latter group, the MRI changes were judged to be due to causes other than X-ALD. Lesions were attributed to X-ALD in the remaining three. Two of these patients had lesions that resembled those in male patients with cerebral X-ALD. In one patient with a mild AMN-like syndrome, brain MRI abnormalities were confined to the corticospinal tract. When compared to those of controls, MRSI studies in eight female patients with normal results on brain MRI showed a significant reduction of N-acetylaspartate/creatine and N-acetylaspartate/choline ratios in the internal capsule and corticospinal projection fibers. The N-acetylaspartate/choline ratio was significantly reduced in the parieto-occipital white matter and the choline/creatine ratio was significantly increased in the frontal white matter.
CONCLUSION: Brain involvement demonstrable by MRI is rare in female subjects heterozygous for X-ALD, including those who have clinical evidence of spinal cord involvement. Nevertheless, N-acetylaspartate levels are reduced in the corticospinal projection fibers in female subjects with normal results on MRI, suggesting axonal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12707433     DOI: 10.1212/01.wnl.0000059546.15529.cb

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

Review 1.  Evaluation of therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser; Ali Fatemi; Kathleen Zackowski; Seth Smith; Xavier Golay; Larry Muenz; Gerald Raymond
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

2.  Heterozygous X-linked adrenoleukodystrophy-associated myelopathy mimicking primary progressive multiple sclerosis.

Authors:  Massimiliano Di Filippo; Elisa Luchetti; Paolo Prontera; Emilio Donti; Piero Floridi; Maria Di Gregorio; Nicola Tambasco; Paola Sarchielli; Paolo Calabresi
Journal:  J Neurol       Date:  2010-08-31       Impact factor: 4.849

Review 3.  Advanced networks and computing in healthcare.

Authors:  Michael Ackerman; Craig Locatis
Journal:  J Am Med Inform Assoc       Date:  2011-04-12       Impact factor: 4.497

4.  Onset of adreno-leukodystrophy after medulloblastoma therapy: causal connection or coincidence?

Authors:  G Deib; A Poretti; A Meoded; K J Cohen; G V Raymond; M Abromowitch; T A G M Huisman
Journal:  JIMD Rep       Date:  2011-09-06

5.  Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy.

Authors:  Bela R Turk; Benjamin E Theisen; Christina L Nemeth; Joel S Marx; Xiaohai Shi; Melissa Rosen; Richard O Jones; Ann B Moser; Paul A Watkins; Gerald V Raymond; Carol Tiffany; Ali Fatemi
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

Review 6.  Therapeutic strategies in adrenoleukodystrophy.

Authors:  Bela R Turk; Ann B Moser; Ali Fatemi
Journal:  Wien Med Wochenschr       Date:  2017-05-10

Review 7.  In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.

Authors:  Erica B Sherry; Phil Lee; In-Young Choi
Journal:  Neurochem Res       Date:  2015-11-26       Impact factor: 3.996

Review 8.  Therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser
Journal:  NeuroRx       Date:  2006-04

Review 9.  Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.

Authors:  Stephan Kemp; Irene C Huffnagel; Gabor E Linthorst; Ronald J Wanders; Marc Engelen
Journal:  Nat Rev Endocrinol       Date:  2016-06-17       Impact factor: 43.330

10.  Seven-Tesla proton magnetic resonance spectroscopic imaging in adult X-linked adrenoleukodystrophy.

Authors:  Eva Ratai; Trina Kok; Christopher Wiggins; Graham Wiggins; Ellen Grant; Borjan Gagoski; Gilmore O'Neill; Elfar Adalsteinsson; Florian Eichler
Journal:  Arch Neurol       Date:  2008-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.